64 |
Graves’ disease in children: an update |
Department of Pediatrics |
2023 |
65 |
Transthoracic ultrasound in the diagnosis and follow up of ventilator associated pneumonia |
Department of Chest Diseases |
2023 |
66 |
Intermittent treatment with Apremilast, a phosphodiesterase-4 inhibitor, ameliorates Alzheimer’s-like pathology and symptoms through multiple targeting actions in aged T2D rats |
Department of Pharmacology |
2023 |
67 |
value of the abbreviated MRI protocol in preoperative assessment of breast cancer |
Department of Diagnostic Radiology |
2023 |
68 |
Antiapoptotic and chemotaxis‑stimulating efects of poly (d, l‑lactide‑co‑glycolide)‑chitosan and whey proteins against afatoxicosis‑induced splenic and thymic atrophy |
Department of Biochemistry |
2023 |
69 |
Beyond the symptoms: Personalizing giant cell arteritis care through multidimensional patient reported outcome measure |
Department of Rheumatology ,Rehabilitation & physical medicine |
2023 |
70 |
Early electrophysiological study variants and their relationship with clinical presentation and outcomes of patients with Guillain-Barré syndrome |
Department of Neurology and Psychiatry |
2023 |
71 |
Effect of Phototherapy on Serum Level of Calcium in Infants with Hyperbilirubinemia |
Department of Pediatrics |
2023 |
72 |
Improving frailty assessment: the task is not finished |
Department of Chest Diseases |
2023 |